Dare Bioscience, INC. 8-K Filing
Ticker: DARE · Form: 8-K · Filed: Oct 25, 2024 · CIK: 1401914
Sentiment: neutral
Filing Stats: 602 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-10-25 08:01:13
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 34KB
- ex99-1_001.jpg (GRAPHIC) — 833KB
- ex99-1_002.jpg (GRAPHIC) — 1558KB
- ex99-1_003.jpg (GRAPHIC) — 964KB
- ex99-1_004.jpg (GRAPHIC) — 1173KB
- ex99-1_005.jpg (GRAPHIC) — 1532KB
- ex99-1_006.jpg (GRAPHIC) — 1218KB
- ex99-1_007.jpg (GRAPHIC) — 1027KB
- ex99-1_008.jpg (GRAPHIC) — 1317KB
- ex99-1_009.jpg (GRAPHIC) — 997KB
- ex99-1_010.jpg (GRAPHIC) — 1472KB
- ex99-1_011.jpg (GRAPHIC) — 1038KB
- ex99-1_012.jpg (GRAPHIC) — 1122KB
- ex99-1_013.jpg (GRAPHIC) — 1249KB
- ex99-1_014.jpg (GRAPHIC) — 1796KB
- ex99-1_015.jpg (GRAPHIC) — 1345KB
- ex99-1_016.jpg (GRAPHIC) — 1228KB
- ex99-1_017.jpg (GRAPHIC) — 1168KB
- ex99-1_018.jpg (GRAPHIC) — 1532KB
- ex99-1_019.jpg (GRAPHIC) — 1291KB
- ex99-1_020.jpg (GRAPHIC) — 1111KB
- ex99-1_021.jpg (GRAPHIC) — 1072KB
- ex99-1_022.jpg (GRAPHIC) — 1049KB
- ex99-1_023.jpg (GRAPHIC) — 554KB
- ex99-1_024.jpg (GRAPHIC) — 1142KB
- ex99-1_025.jpg (GRAPHIC) — 774KB
- ex99-1_026.jpg (GRAPHIC) — 686KB
- ex99-1_027.jpg (GRAPHIC) — 1187KB
- ex99-1_028.jpg (GRAPHIC) — 1333KB
- ex99-1_029.jpg (GRAPHIC) — 1797KB
- ex99-1_030.jpg (GRAPHIC) — 1055KB
- ex99-1_031.jpg (GRAPHIC) — 1437KB
- ex99-1_032.jpg (GRAPHIC) — 1265KB
- ex99-1_033.jpg (GRAPHIC) — 1188KB
- ex99-1_034.jpg (GRAPHIC) — 985KB
- ex99-1_035.jpg (GRAPHIC) — 1259KB
- ex99-1_036.jpg (GRAPHIC) — 1184KB
- ex99-1_037.jpg (GRAPHIC) — 963KB
- ex99-1_038.jpg (GRAPHIC) — 881KB
- ex99-1_039.jpg (GRAPHIC) — 1446KB
- ex99-1_040.jpg (GRAPHIC) — 1381KB
- ex99-1_041.jpg (GRAPHIC) — 570KB
- 0001493152-24-042455.txt ( ) — 66531KB
- dare-20241025.xsd (EX-101.SCH) — 3KB
- dare-20241025_lab.xml (EX-101.LAB) — 33KB
- dare-20241025_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DAR BIOSCIENCE, INC. Dated: October 25, 2024 By: /s/ Sabrina Martucci Johnson Name: Sabrina Martucci Johnson Title: President and Chief Executive Officer -3-